Scribd
Upload
41 views5 pages

Ocular Drug Delivery Market Is Expected To Reach US$ 27,016.20 Million by 2028

The Ocular Drug Delivery Market is projected to grow from US$ 16,404.32 million in 2021 to US$ 27,016.20 million by 2028, with a CAGR of 7.4%. The market is segmented by technology, formulation type, disease type, and end user, addressing various ocular conditions such as glaucoma and diabetic retinopathy. Key players in the market include AbbVie Inc., Bausch Health Companies Inc., and Novartis AG.

Uploaded by

Anirudha
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
41 views5 pages

Ocular Drug Delivery Market Is Expected To Reach US$ 27,016.20 Million by 2028

The Ocular Drug Delivery Market is projected to grow from US$ 16,404.32 million in 2021 to US$ 27,016.20 million by 2028, with a CAGR of 7.4%. The market is segmented by technology, formulation type, disease type, and end user, addressing various ocular conditions such as glaucoma and diabetic retinopathy. Key players in the market include AbbVie Inc., Bausch Health Companies Inc., and Novartis AG.

Uploaded by

Anirudha
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 5

Ocular Drug Delivery Market

Ocular Drug Delivery Market Forecast to


2028 - COVID-19 Impact and Global Analysis
By Technology (Implantable Ocular Drug
Delivery Systems, Particulate Drug Delivery
Systems, Nano-Particle Drug Delivery
System, and Others), Formulation Type
(Liposomes and Nanoparticles, Solution,
Emulsion, Suspension, and Ointment),
Disease Type (Glaucoma, Diabetic
Retinopathy, Dry Eye Syndrome, Macular
Degeneration, Cataract, Diabetic Macular
Edema, and Others), and End User
(Hospitals, Ophthalmic Clinics, and
Ambulatory Surgical Centers) and
Geography
Ocular Drug Delivery Market

Current and future Market Scenario

According to our new market research study on “Ocular Drug Delivery Market to 2028 – Global Analysis and Forecast – by
Technology, Formulation Type, Disease Type, and End User,” the market is expected to reach US$ 27,016.20 million by 2028
from US$ 16,404.32 million in 2021; it is expected to grow at a CAGR of 7.4% from 2021 to 2028. The report highlights trends
prevailing in the market and drivers and hindrances pertaining to the market growth.
Ocular Drug Delivery Market

Market Segments

By Disease Type
By Formulation Type
By Technology Glaucoma,
Liposomes and Nanoparticles,
Implantable Ocular Drug Delivery Diabetic Retinopathy,
Solution,
Systems Dry Eye Syndrome,
Emulsion,
Particulate Drug Delivery Systems, Macular Degeneration,
Suspension,
Nano-Particle Drug Delivery System, Cataract,
Ointment
Others Diabetic Macular Edema,
Others
Ocular Drug Delivery Market

Leading Players

Company Profiles in Ocular Drug Delivery Market are:


AbbVie Inc.
Bausch Health Companies Inc.
Taiwan Liposome Company, Ltd.
Ocular Therapeutix, Inc.
GRAYBUG VISION, INC.
Alimera Sciences, Inc.
Envisia Therapeutics
Novartis AG
EYEGATE PHARMACEUTICALS, INC
Clearside Biomedical, Inc.
Ocular Drug Delivery Market

Access Full Research Report at:


https://www.theinsightpartners.com/sample/TIPRE00004206/

Thank You!

Thank You!

You might also like